LG Uplus Corp and its global partners have developed cellular module technology using Universal Integrated Circuit Card (iUICC) solutions that do away with Subscriber Identification Module (SIM) cards in mobile devices.
The partners include cellular chipset developer Sony Semiconductor Israel, German digital security solutions provider Giesecke+Devrient, and local communication module maker NTmore.
The latest technology will allow manufacturers to produce smaller devices with the space saved for a SIM card and related components.
The iUICC implements a communication chipset's SIM functionality that is responsible for voice and data connection.
LG Uplus plans to initially use iUICC technology on the Internet of Things products, such as for tracking devices and outdoor inspection equipment.
LG Uplus is South Korea's third-largest mobile carrier.


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



